$NRXP I don't know what relief therapeutic company executives think. The stock price of this company and its partner nrxp has become almost equal to that of hgen, which failed fda eua. After Relief said he would file a lawsuit even though he had nothing to gain, the stock price was cut in half, and the current incompetent manager needs to be changed at the general meeting.
5
4
4 Likes